title: To What did They Consent? Understanding Consent Among Low Literacy Participants in a Microbicide Feasibility Study in Mazabuka, Zambia.
abstract: We conducted a study to review the consenting process in a vaginal microbicide feasibility study conducted in Mazabuka, Zambia. Participants were drawn from those participating in the microbicide study. A questionnaire and focus group discussion were used to collect information on participants' understanding of study aims, risks and benefits. Altogether, 200 participants took part in this study. The results of the study showed that while all participants signed or endorsed their thumbprints to the consent forms, full informed consent was not attained from most of the participants since 77% (n = 154) of the participants had numerous questions about the study and 34% (n = 68) did not know who to get in touch with concerning the study. Study objectives were not fully understood by over 61% of the participants. Sixty four percent of the participants were not sure of the risks of taking part in the microbicide study. A significant number thought the study was all about determining their HIV status. Some participants were concerned that their partners were not on the trial as they were convinced that being on the study meant that that they had a lifetime protection from HIV infection. The process of obtaining consent was inadequate as various phases of the study were not fully understood. We recommend the need for researchers to reinforce the consenting process in all studies and more so when studies are conducted in low literacy populations.
authors.forename: Esther
authors.initials: E
authors.lastname: Munalula-Nkandu
authors.forename: Paul
authors.initials: P
authors.lastname: Ndebele
authors.forename: Seter
authors.initials: S
authors.lastname: Siziya
authors.forename: J C
authors.initials: JC
authors.lastname: Munthali
mesh_terms: D000282:Administration, Intravaginal; D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D035843:Biomedical Research / Q000941:ethics*; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D004358:Drug Therapy / Q000941:ethics; D005260:Female; D015658:HIV Infections / Q000517:prevention & control; D006801:Humans; D007258:Informed Consent / Q000592:standards*; D007407:Interviews as Topic; D000067010:Literacy; D008297:Male; D008875:Middle Aged; D065129:Pre-Exposure Prophylaxis / Q000379:methods; D055815:Young Adult; D015024:Zambia
chemical_list: D000890:Anti-Infective Agents
keywords: Africa; Consent; HIV/AIDS; antiretroviral therapy; developing world; information supplied in informed consent; informed consent